Can facing fears help treat anorexia? new study tests exposure therapy
NCT ID NCT06171711
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study is testing a new type of exposure therapy for people with anorexia nervosa. The therapy helps patients face their fears about eating and weight gain through real-life and mental exercises. The study involves 30 participants and aims to see if the therapy is feasible, acceptable, and helpful in reducing symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Exposure therapy (behavioral intervention combining real-life and mental exposure to feared foods and weight gain scenarios)
- What this could lead to
- If it works, this could point toward a more effective treatment for anorexia nervosa that helps people overcome fear of food and weight gain.
- What could go wrong
- This is a very small pilot study with only 30 participants, so results may not apply widely. It is early-stage research, and the therapy may not prove effective or acceptable to all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2024
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
17 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Participants will be English speakers, ages 17 - 65 years, of all genders, with AN-spectrum disorders, defined as a diagnosis of AN, atypical AN, or AN in partial remission. 1. Participants with AN, atypical AN, and AN in partial remission share the same DSM-5 criteria, with the exception of criterion A: "Significantly low body weight." 2. Individuals with atypical AN are weight suppressed, but not "objectively" underweight (e.g., someone who experiences rapid weight loss from a BMI of 27 to 21). Those with AN in partial remission are partially or fully weight restored (e.g., after stepping down from an inpatient setting), but continue to experience significant AN behaviors (e.g., food avoidance) and/or cognitions (e.g., fear of weight gain). 3. Diagnoses will be determined using the Structured Clinical Interview for DSM-5 - Research Version (SCID-5-RV).93 All participants in this study will be monitored by a Penn State Health medical provider. 2. All individuals who are deemed to be, or become, unsafe by their supervising medical provider will be admitted to our hospital or another facility for medical stabilization. Exclusion Criteria: 1. Participants will be excluded if they are below 18 years of age. 2. Those identified as non-English speakers will be excluded due to lack of funding to translate the measures to other languages. 3. Individuals with other EDs (e.g., bulimia nervosa) will be excluded. 4. Participants will be excluded if they are: a.at high risk for suicide i.Suicide risk will be determined using the Columbia Suicide Severity Rating Scale (CSSRS) screen. The CSSRS will be administered by the study coordinator when they initially meet with the participant for Session 0 (see section 7 of this protocol), and at the start of every weekly session with the study therapist. The study coordinator and study therapists will be trained by the PI to adhere to a Suicide Assessment Protocol. This protocol will state that all participants who report high suicide risk should be sent by an ambulance to our institution's emergency department. b.pregnant determined by verbal verification (the study coordinator will ask participants if they are pregnant when completing the eligibility checklist and/or during the informed consent process). c. Meet DSM-5 criteria for a psychotic disorder and/or have an intellectual disability.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anorexia nervosa are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
905 W Govener Rd
Hershey, Pennsylvania, 17033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise and Self-Control shield kids from binge eating?
- Can a group program stop eating disorders in type 1 diabetes?
- Can the Brain's Information-Integration process explain Anorexia's grip?
- Can schools catch teen mental health struggles before they escalate?
- A video Game-Style app takes on eating disorder prevention
- Can a pudding snack reveal how the brain misreads the stomach?